MacKay-Lyons M
School of Physiotherapy, Dalhousie University, Halifax, Nova Scotia, Canada.
Phys Ther. 1998 Oct;78(10):1083-94. doi: 10.1093/ptj/78.10.1083.
Understanding the nature and extent of fluctuations in spatial and temporal variables of gait (eg, speed, stride length [SL], stride time [ST]) over the course of the levodopa (L-dopa) cycle of individuals with advanced Parkinson disease (PD) is important in order to assess patients and examine the effectiveness of interventions. The purpose of this study was to determine whether gait variables are sufficiently stable to be used as outcome measures in a clinical trial involving patients with advanced PD.
Five volunteers (3 male, 2 female; mean age=67.8 years; Hoehn and Yahr stages 3-4) with idiopathic PD of a mean duration of 15.0 years participated.
Gait speed, SL, and ST were measured as the subjects walked 7.2 m at self-selected speeds. To evaluate the full "on-off" sequence of the L-dopa response, this analysis was repeated 11 times, at intervals of 10% of the L-dopa cycle. Each subject was analyzed on 3 separate days, with approximately 1 month between tests. Two-way repeated-measures analyses of covariance, with 2 within-subject factors (percentage of L-dopa cycle and day) and 1 covariate (height), were applied, and coefficients of variation were calculated to determine the extent of change in speed, SL, and ST over the L-dopa cycle and over the 3 days.
The subjects' overall mean gait speed was 70.39 cm/s, representing 55.4% of the age-related normative values. There were no effects of percentage of the L-dopa cycle or day or of the interaction of percentage of the L-dopa cycle and day on speed, SL, and ST. The coefficients of variation for speed and SL were consistently higher than the normative values, ranging from 13.5% to 23.8% and from 13.9% to 23.3% at 20% of the L-dopa cycle, respectively.
When interpreting spatiotemporal measurements of gait of patients with advanced PD, fluctuations can be extensive and may not follow a predictable pattern.
了解晚期帕金森病(PD)患者左旋多巴(L -多巴)周期中步态的空间和时间变量(如速度、步长[SL]、步幅时间[ST])波动的性质和程度,对于评估患者和检验干预措施的有效性至关重要。本研究的目的是确定在涉及晚期PD患者的临床试验中,步态变量是否足够稳定,可作为疗效指标。
五名特发性PD志愿者(3名男性,2名女性;平均年龄 = 67.8岁;Hoehn - Yahr分级3 - 4级)参与,平均病程为15.0年。
受试者以自选速度行走7.2米时测量步态速度、步长和步幅时间。为评估L -多巴反应的完整“开 - 关”序列,该分析重复11次,间隔为L -多巴周期的10%。每位受试者在3个不同日期进行分析,测试间隔约1个月。应用双向重复测量协方差分析,包含2个受试者内因素(L -多巴周期百分比和日期)和1个协变量(身高),并计算变异系数以确定L -多巴周期和3天内速度、步长和步幅时间的变化程度。
受试者的总体平均步态速度为70.39厘米/秒,占年龄相关正常值的55.4%。L -多巴周期百分比、日期或L -多巴周期百分比与日期的交互作用对速度、步长和步幅时间均无影响。速度和步长的变异系数始终高于正常值,在L -多巴周期的20%时,分别为13.5%至23.8%和13.9%至23.3%。
在解释晚期PD患者的步态时空测量结果时,波动可能很大,且可能不遵循可预测的模式。